{"id":753143,"date":"2023-05-01T12:30:17","date_gmt":"2023-05-01T16:30:17","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-iveric-bio-inc-nasdaq-isee-midwest-holding-inc-nasdaq-mdwt-hoth-therapeutics-i\/"},"modified":"2023-05-01T12:30:17","modified_gmt":"2023-05-01T16:30:17","slug":"brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-iveric-bio-inc-nasdaq-isee-midwest-holding-inc-nasdaq-mdwt-hoth-therapeutics-i","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-iveric-bio-inc-nasdaq-isee-midwest-holding-inc-nasdaq-mdwt-hoth-therapeutics-i\/","title":{"rendered":"BRODSKY &amp; SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Iveric Bio Inc. (Nasdaq \u2013 ISEE), Midwest Holding Inc. (Nasdaq \u2013 MDWT), Hoth Therapeutics, Inc. (Nasdaq \u2013 HOTH)"},"content":{"rendered":"<div class=\"mw_release\">\n<p>BALA CYNWYD, Pa., May  01, 2023  (GLOBE NEWSWIRE) &#8212; Brodsky &amp; Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=67KJhJvm1OyJIwgwic1fXshh7mkg_pnQSbAHMNs3pdUqmtPSQNq0wtX5dX-UmVXf17ylk89svRWlf3aLB6PLV1nrIhCfZcr8XrLAWsUIy4Y=\" rel=\"nofollow noopener\" target=\"_blank\">jbrodsky@brodskysmith.com<\/a>) or Marc Ackerman (<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=oNZgpbEkQL5sVT06tCaB0wCVXQeRNJbi2qeU91xhVvlm2KZgMmBZipVvustzSN3WHyHZtaA3TTxuXsO-bS5VNlWPmHcPZ1_sQcF_RiIY58EJpUWfeyr7IEVeoqvwjmLd\" rel=\"nofollow noopener\" target=\"_blank\">mackerman@brodskysmith.com<\/a>) at 855-576-4847. There is no cost or financial obligation to you.<\/p>\n<p>\n        <strong>Iveric Bio Inc. (Nasdaq \u2013 ISEE)<\/strong>\n      <\/p>\n<p align=\"justify\">Under the terms of the Merger Agreement, Iveric Bio will be acquired by Astellas Pharma Inc. (\u201cAstellas\u201d). Iveric Bio shareholders will receive $40.00 in cash for each share of Iveric Bio they own for a total equity value of approximately US$5.9 billion.The investigation concerns whether the Iveric Bio Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether Astellas is paying too little for the Company.<\/p>\n<p>Additional information can be found at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=guS9xuolhtTDvsE91zDfpu-zAwUg61hlmN2qQJPGhd_W3hiWMWoMxAacLm1w4izo-qRM9NRJGd2q5shJGA45tgaCIShOfOnZtseF-zvhocId1PabZICQbtzgz2cU2Rxao1mBJCrcl9V9yT_WSVoHK-bhhWKwKdzVXjrZ273BO5cFI3hFPTwBAHheRlM1NqbJbqjLnWMsfNqcFS9Yh1BWOA==\" rel=\"nofollow noopener\" target=\"_blank\">https:\/\/www.brodskysmith.com\/cases\/iveric-bio-inc-nasdaq-isee\/<\/a>.<\/p>\n<p>\n        <strong>Midwest Holding Inc. (Nasdaq \u2013 MDWT)<\/strong>\n      <\/p>\n<p align=\"justify\">Under the terms of the Merger Agreement, Midwest Holding will be acquired by Antarctica Capital (\u201cAntarctica\u201d). Midwest Holding shareholders will receive $27.00 in cash for each share of Midwest Holding they own. The investigation concerns whether the Midwest Holding Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether Antarctica is paying too little for the Company.<\/p>\n<p>Additional information can be found at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=guS9xuolhtTDvsE91zDfpu-zAwUg61hlmN2qQJPGhd80bGaeDX-5QNXhjzYF4OIvXzP5_f0hi5Da0DlyBv8bKSNHXVJCnJ9NRKW0tixZYfZzrwbfUU82JApQKhT3DBDG7kdfmZWx7NMyrT0kBfrT4YpFGcudcvrkzxBVoSKDyL8ErB8ZD41cq4H3ZG9ArdL0ybo8HJkJXwSiul2JQcNOAw==\" rel=\"nofollow noopener\" target=\"_blank\">https:\/\/www.brodskysmith.com\/cases\/midwest-holding-inc-nasdaq-mdwt\/<\/a>.<\/p>\n<p>\n        <strong>Hoth Therapeutics, Inc. (Nasdaq \u2013 HOTH)<\/strong>\n      <\/p>\n<p align=\"justify\">Under the terms of the agreement, Hoth will be acquired by Algorithm Sciences, Inc. (\u201cAlgorithm\u201d). On a pro forma basis and based upon the number of shares of Hoth common stock to be issued in the merger, current Hoth shareholders are currently anticipated to own approximately 14% of the combined company and current Algorithm shareholders are currently anticipated to own approximately 86% of the combined company. The investigation concerns whether the Hoth Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including the dilution of Hoth shareholders in the combined company.<\/p>\n<p>Additional information can be found at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=guS9xuolhtTDvsE91zDfpu-zAwUg61hlmN2qQJPGhd-vvgTWv5_5k9ZiCfNpdS_t1s_6Zsl-eiIc9k5PhwAh3knmp5hl1YURTm9HIcvcPnMAyTrQ2c38OwWjNc_CYyPO_YcqE6XVOvY12tBmOGA-FzgZ3sLffz9km1fB4TX64LTMYQVHk9q3_Gj8NER9OWghhaJJAzHO3DyCMxjojeuQ-g==\" rel=\"nofollow noopener\" target=\"_blank\">https:\/\/www.brodskysmith.com\/cases\/hoth-therapeutics-inc-nasdaq-hoth<\/a>.<\/p>\n<p>Brodsky &amp; Smith is a litigation law firm with extensive expertise representing shareholders throughout the nation in securities and class action lawsuits. The attorneys at Brodsky &amp; Smith have been appointed by numerous courts throughout the country to serve as lead counsel in class actions and have successfully recovered millions of dollars for our clients and shareholders. Attorney advertising. Prior results do not guarantee a similar outcome.<\/p>\n<p \/>\n      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgyOTEzNCM1NTY3Mzc0IzIxODgyNzg=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/YjIwOTI4ZjgtNTkzMS00N2JmLWI4MjMtNTg0YTQyOTE0NGVkLTExOTk4MzE=\/tiny\/Brodsky-Smith-LLC.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>BALA CYNWYD, Pa., May 01, 2023 (GLOBE NEWSWIRE) &#8212; Brodsky &amp; Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you. Iveric Bio Inc. (Nasdaq \u2013 ISEE) Under the terms of the Merger Agreement, Iveric Bio will be acquired by Astellas Pharma Inc. (\u201cAstellas\u201d). Iveric Bio shareholders will receive $40.00 in cash for each share of Iveric Bio they own for a total equity value of approximately US$5.9 billion.The investigation concerns whether the Iveric Bio Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether Astellas is paying &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-iveric-bio-inc-nasdaq-isee-midwest-holding-inc-nasdaq-mdwt-hoth-therapeutics-i\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;BRODSKY &amp; SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Iveric Bio Inc. (Nasdaq \u2013 ISEE), Midwest Holding Inc. (Nasdaq \u2013 MDWT), Hoth Therapeutics, Inc. (Nasdaq \u2013 HOTH)&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-753143","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>BRODSKY &amp; SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Iveric Bio Inc. (Nasdaq \u2013 ISEE), Midwest Holding Inc. (Nasdaq \u2013 MDWT), Hoth Therapeutics, Inc. (Nasdaq \u2013 HOTH) - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-iveric-bio-inc-nasdaq-isee-midwest-holding-inc-nasdaq-mdwt-hoth-therapeutics-i\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"BRODSKY &amp; SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Iveric Bio Inc. (Nasdaq \u2013 ISEE), Midwest Holding Inc. (Nasdaq \u2013 MDWT), Hoth Therapeutics, Inc. (Nasdaq \u2013 HOTH) - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"BALA CYNWYD, Pa., May 01, 2023 (GLOBE NEWSWIRE) &#8212; Brodsky &amp; Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you. Iveric Bio Inc. (Nasdaq \u2013 ISEE) Under the terms of the Merger Agreement, Iveric Bio will be acquired by Astellas Pharma Inc. (\u201cAstellas\u201d). Iveric Bio shareholders will receive $40.00 in cash for each share of Iveric Bio they own for a total equity value of approximately US$5.9 billion.The investigation concerns whether the Iveric Bio Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether Astellas is paying &hellip; Continue reading &quot;BRODSKY &amp; SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Iveric Bio Inc. (Nasdaq \u2013 ISEE), Midwest Holding Inc. (Nasdaq \u2013 MDWT), Hoth Therapeutics, Inc. (Nasdaq \u2013 HOTH)&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-iveric-bio-inc-nasdaq-isee-midwest-holding-inc-nasdaq-mdwt-hoth-therapeutics-i\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-05-01T16:30:17+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgyOTEzNCM1NTY3Mzc0IzIxODgyNzg=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-iveric-bio-inc-nasdaq-isee-midwest-holding-inc-nasdaq-mdwt-hoth-therapeutics-i\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-iveric-bio-inc-nasdaq-isee-midwest-holding-inc-nasdaq-mdwt-hoth-therapeutics-i\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"BRODSKY &amp; SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Iveric Bio Inc. (Nasdaq \u2013 ISEE), Midwest Holding Inc. (Nasdaq \u2013 MDWT), Hoth Therapeutics, Inc. (Nasdaq \u2013 HOTH)\",\"datePublished\":\"2023-05-01T16:30:17+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-iveric-bio-inc-nasdaq-isee-midwest-holding-inc-nasdaq-mdwt-hoth-therapeutics-i\\\/\"},\"wordCount\":422,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-iveric-bio-inc-nasdaq-isee-midwest-holding-inc-nasdaq-mdwt-hoth-therapeutics-i\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgyOTEzNCM1NTY3Mzc0IzIxODgyNzg=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-iveric-bio-inc-nasdaq-isee-midwest-holding-inc-nasdaq-mdwt-hoth-therapeutics-i\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-iveric-bio-inc-nasdaq-isee-midwest-holding-inc-nasdaq-mdwt-hoth-therapeutics-i\\\/\",\"name\":\"BRODSKY &amp; SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Iveric Bio Inc. (Nasdaq \u2013 ISEE), Midwest Holding Inc. (Nasdaq \u2013 MDWT), Hoth Therapeutics, Inc. (Nasdaq \u2013 HOTH) - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-iveric-bio-inc-nasdaq-isee-midwest-holding-inc-nasdaq-mdwt-hoth-therapeutics-i\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-iveric-bio-inc-nasdaq-isee-midwest-holding-inc-nasdaq-mdwt-hoth-therapeutics-i\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgyOTEzNCM1NTY3Mzc0IzIxODgyNzg=\",\"datePublished\":\"2023-05-01T16:30:17+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-iveric-bio-inc-nasdaq-isee-midwest-holding-inc-nasdaq-mdwt-hoth-therapeutics-i\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-iveric-bio-inc-nasdaq-isee-midwest-holding-inc-nasdaq-mdwt-hoth-therapeutics-i\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-iveric-bio-inc-nasdaq-isee-midwest-holding-inc-nasdaq-mdwt-hoth-therapeutics-i\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgyOTEzNCM1NTY3Mzc0IzIxODgyNzg=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgyOTEzNCM1NTY3Mzc0IzIxODgyNzg=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-iveric-bio-inc-nasdaq-isee-midwest-holding-inc-nasdaq-mdwt-hoth-therapeutics-i\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"BRODSKY &amp; SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Iveric Bio Inc. (Nasdaq \u2013 ISEE), Midwest Holding Inc. (Nasdaq \u2013 MDWT), Hoth Therapeutics, Inc. (Nasdaq \u2013 HOTH)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"BRODSKY &amp; SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Iveric Bio Inc. (Nasdaq \u2013 ISEE), Midwest Holding Inc. (Nasdaq \u2013 MDWT), Hoth Therapeutics, Inc. (Nasdaq \u2013 HOTH) - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-iveric-bio-inc-nasdaq-isee-midwest-holding-inc-nasdaq-mdwt-hoth-therapeutics-i\/","og_locale":"en_US","og_type":"article","og_title":"BRODSKY &amp; SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Iveric Bio Inc. (Nasdaq \u2013 ISEE), Midwest Holding Inc. (Nasdaq \u2013 MDWT), Hoth Therapeutics, Inc. (Nasdaq \u2013 HOTH) - Market Newsdesk","og_description":"BALA CYNWYD, Pa., May 01, 2023 (GLOBE NEWSWIRE) &#8212; Brodsky &amp; Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you. Iveric Bio Inc. (Nasdaq \u2013 ISEE) Under the terms of the Merger Agreement, Iveric Bio will be acquired by Astellas Pharma Inc. (\u201cAstellas\u201d). Iveric Bio shareholders will receive $40.00 in cash for each share of Iveric Bio they own for a total equity value of approximately US$5.9 billion.The investigation concerns whether the Iveric Bio Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether Astellas is paying &hellip; Continue reading \"BRODSKY &amp; SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Iveric Bio Inc. (Nasdaq \u2013 ISEE), Midwest Holding Inc. (Nasdaq \u2013 MDWT), Hoth Therapeutics, Inc. (Nasdaq \u2013 HOTH)\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-iveric-bio-inc-nasdaq-isee-midwest-holding-inc-nasdaq-mdwt-hoth-therapeutics-i\/","og_site_name":"Market Newsdesk","article_published_time":"2023-05-01T16:30:17+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgyOTEzNCM1NTY3Mzc0IzIxODgyNzg=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-iveric-bio-inc-nasdaq-isee-midwest-holding-inc-nasdaq-mdwt-hoth-therapeutics-i\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-iveric-bio-inc-nasdaq-isee-midwest-holding-inc-nasdaq-mdwt-hoth-therapeutics-i\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"BRODSKY &amp; SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Iveric Bio Inc. (Nasdaq \u2013 ISEE), Midwest Holding Inc. (Nasdaq \u2013 MDWT), Hoth Therapeutics, Inc. (Nasdaq \u2013 HOTH)","datePublished":"2023-05-01T16:30:17+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-iveric-bio-inc-nasdaq-isee-midwest-holding-inc-nasdaq-mdwt-hoth-therapeutics-i\/"},"wordCount":422,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-iveric-bio-inc-nasdaq-isee-midwest-holding-inc-nasdaq-mdwt-hoth-therapeutics-i\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgyOTEzNCM1NTY3Mzc0IzIxODgyNzg=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-iveric-bio-inc-nasdaq-isee-midwest-holding-inc-nasdaq-mdwt-hoth-therapeutics-i\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-iveric-bio-inc-nasdaq-isee-midwest-holding-inc-nasdaq-mdwt-hoth-therapeutics-i\/","name":"BRODSKY &amp; SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Iveric Bio Inc. (Nasdaq \u2013 ISEE), Midwest Holding Inc. (Nasdaq \u2013 MDWT), Hoth Therapeutics, Inc. (Nasdaq \u2013 HOTH) - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-iveric-bio-inc-nasdaq-isee-midwest-holding-inc-nasdaq-mdwt-hoth-therapeutics-i\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-iveric-bio-inc-nasdaq-isee-midwest-holding-inc-nasdaq-mdwt-hoth-therapeutics-i\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgyOTEzNCM1NTY3Mzc0IzIxODgyNzg=","datePublished":"2023-05-01T16:30:17+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-iveric-bio-inc-nasdaq-isee-midwest-holding-inc-nasdaq-mdwt-hoth-therapeutics-i\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-iveric-bio-inc-nasdaq-isee-midwest-holding-inc-nasdaq-mdwt-hoth-therapeutics-i\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-iveric-bio-inc-nasdaq-isee-midwest-holding-inc-nasdaq-mdwt-hoth-therapeutics-i\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgyOTEzNCM1NTY3Mzc0IzIxODgyNzg=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgyOTEzNCM1NTY3Mzc0IzIxODgyNzg="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-iveric-bio-inc-nasdaq-isee-midwest-holding-inc-nasdaq-mdwt-hoth-therapeutics-i\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"BRODSKY &amp; SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Iveric Bio Inc. (Nasdaq \u2013 ISEE), Midwest Holding Inc. (Nasdaq \u2013 MDWT), Hoth Therapeutics, Inc. (Nasdaq \u2013 HOTH)"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/753143","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=753143"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/753143\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=753143"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=753143"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=753143"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}